This study investigated the persistent circulation of Rift Valley fever virus (RVFV) lineage C in Rwanda over a multi-year period from 2022 to 2025, examining viral spread and maintenance in the region.
The paper abstract provides limited detail on sample sizes, specific outcomes, or methodology, making it difficult to assess the full scope of findings.
Clinicians and public health practitioners in East Africa should remain alert to ongoing RVFV transmission risk in Rwanda, as lineage C appears to have established persistent circulation beyond single outbreak events.
